News
Medtronic is one of the largest pure-play medical device stocks you can buy. The stock is yielding a historically attractive ...
CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward ...
1d
Stocktwits on MSNCMS’s Initial Proposal To Cover Renal Denervation A Win For Medtronic, Says AnalystsAnalysts are optimistic about Medtronic (MDT) after the Centers for Medicare and Medicaid Services (CMS) proposed to cover ...
Medtronic (NYSE:MDT) experienced a price increase of 7% over the last quarter, which may have been influenced by notable ...
4d
Stocktwits on MSNMedtronic Names CFO For New Diabetes Company Ahead Of Intended Spin-OffHealth technology company Medtronic plc (MDT) on Tuesday announced the appointment of Chad Spooner as CFO of MiniMed. The ...
The healthcare industry is a behemoth, with annual expenditures totaling $4.9 trillion in the United States alone. It's a ...
The company named Chad Spooner CFO of MiniMed ahead of plans to spin out the diabetes unit into a separate public firm.
Goldman Sachs analyst David Roman reiterated a Sell rating on Medtronic today and set a price target of $78.00. The company’s shares closed today at $89.92. Take advantage of TipRanks Premium at 50% ...
Medtronic is studying the use of its nitinol-enabled Symplicity Spyral renal denervation (RDN) catheter combined with hepatic ...
Nearly 70 years into her history, Barbie is still undergoing regular makeovers. | Nearly 70 years into her history, Barbie is ...
Ivan Fong, 63, was one of the highest-proifile GCs to sign an amicus brief supporting Perkins Coie's legal challenge of ...
Medtronic PLC closed 7.97% below its 52-week high of $96.25, which the company achieved on March 10th.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results